Teams Announced for the 2024 StaffDNA® Cure Bowl
PLANO, Texas, Dec. 9, 2024 /PRNewswire/ -- ESPN Events along with the Orlando Sports Foundation (OSF) announced that Jacksonville State...
DNA
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
Strong Eversense® 365 early launch indicators illustrated by largest number of new patient shipments and largest number of prescribing providers...
Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies...
Aionics Unveils Expansion into Aviation Batteries Fueled by Strategic Investments and Industry Partnerships
Company will leverage recent financing and joint development agreement with electric aviation manufacturing partner to develop safer and more efficient...
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISSCollaboration Aims to Enhance Healthspan on Earth and Improve Astronaut...
Medicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA® (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study
70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination...
Demonstrating commitment to continuous portfolio innovation, Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Guidewire Handle and launches its latest software advancements
CLEVELAND, Dec. 4, 2024 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovative leader in cardiovascular navigation and visualization systems, announced...
Up to $1.6 Million in Funding Available for NSF Tissue Engineering Research Utilizing the ISS National Lab
Solicitation now open for multiple awards supporting space-based tissue engineering and mechanobiology research KENNEDY SPACE CENTER, Fla., Dec. 4, 2024...
Codetta Bio Welcomes Paul McEwan and Mitch Levine as Independent Board Members
MORRISVILLE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in integrated multi-omics solutions, is proud to announce...
X4 Pharmaceuticals to Present Trial-in-Progress Poster on Phase 3 Study of Mavorixafor in Chronic Neutropenia at 66th ASH Annual Meeting & Exposition
Pivotal Phase 3 4WARD clinical trial is evaluating use of oral mavorixafor as monotherapy and in combination with injectable G-CSFBOSTON,...
NAPA Anesthesia Improves Patient Payment Satisfaction and Online Bill Pay Experience, Along with a Payment Lift
With Cedar Pay, NAPA has streamlined the payment process and increased payments from patients with balances after insurance by 71%...
Dr. Alexander Taghva Introduces Focused Ultrasound Treatment for Essential Tremors in Orange County, CA
Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /...
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root,...
Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma
First program to result from end-to-end use of OS to identify a novel target and new chemical matter, which moved...
Palisade Bio Announces Preliminary Data from Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis Appears to be Safe and Well Tolerated in Treated Subjects
First three Single Ascending Dose cohorts demonstrated no treatment related adverse events Carlsbad, CA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Palisade...
Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024
6-month efficacy and safety data from ongoing Phase 1/2 trial of OPGx-LCA5 to be presentedFARMINGTON HILLS, Mich., Dec. 03, 2024...
Excision BioTherapeutics Announces Oral Presentation at the 5th Genome Editing Therapeutics Summit
SAN FRANCISCO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a biotechnology company developing CRISPR-based therapies...
Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical...
Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting
SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
Five-year renewable agreement secures reliable cGMP rhenium-186 (Re-186) supply for late-stage clinical and commercial forecastsAUSTIN, Texas, Dec. 03, 2024 (GLOBE...